1. Home
  2. AVAV vs VTRS Comparison

AVAV vs VTRS Comparison

Compare AVAV & VTRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AVAV
  • VTRS
  • Stock Information
  • Founded
  • AVAV 1971
  • VTRS 1961
  • Country
  • AVAV United States
  • VTRS United States
  • Employees
  • AVAV N/A
  • VTRS N/A
  • Industry
  • AVAV Aerospace
  • VTRS Medicinal Chemicals and Botanical Products
  • Sector
  • AVAV Industrials
  • VTRS Health Care
  • Exchange
  • AVAV Nasdaq
  • VTRS Nasdaq
  • Market Cap
  • AVAV 12.0B
  • VTRS 11.8B
  • IPO Year
  • AVAV 2007
  • VTRS N/A
  • Fundamental
  • Price
  • AVAV $247.47
  • VTRS $10.42
  • Analyst Decision
  • AVAV Strong Buy
  • VTRS Hold
  • Analyst Count
  • AVAV 13
  • VTRS 5
  • Target Price
  • AVAV $282.62
  • VTRS $10.40
  • AVG Volume (30 Days)
  • AVAV 757.3K
  • VTRS 9.6M
  • Earning Date
  • AVAV 09-09-2025
  • VTRS 08-07-2025
  • Dividend Yield
  • AVAV N/A
  • VTRS 4.61%
  • EPS Growth
  • AVAV N/A
  • VTRS N/A
  • EPS
  • AVAV 1.55
  • VTRS N/A
  • Revenue
  • AVAV $820,627,000.00
  • VTRS $14,115,700,000.00
  • Revenue This Year
  • AVAV $149.08
  • VTRS N/A
  • Revenue Next Year
  • AVAV $15.36
  • VTRS $1.66
  • P/E Ratio
  • AVAV $159.86
  • VTRS N/A
  • Revenue Growth
  • AVAV 14.50
  • VTRS N/A
  • 52 Week Low
  • AVAV $102.25
  • VTRS $6.85
  • 52 Week High
  • AVAV $295.90
  • VTRS $13.55
  • Technical
  • Relative Strength Index (RSI)
  • AVAV 49.62
  • VTRS 63.12
  • Support Level
  • AVAV $227.55
  • VTRS $10.55
  • Resistance Level
  • AVAV $254.00
  • VTRS $10.82
  • Average True Range (ATR)
  • AVAV 10.52
  • VTRS 0.28
  • MACD
  • AVAV -1.18
  • VTRS 0.00
  • Stochastic Oscillator
  • AVAV 54.28
  • VTRS 74.52

About AVAV AeroVironment Inc.

AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky. The company is a defense technology provider delivering integrated capabilities across air, land, sea, space, and cyber. It develops and deploy autonomous systems, precision strike systems, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities.

About VTRS Viatris Inc.

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

Share on Social Networks: